tradingkey.logo
搜尋

Resmed Inc

RMD
添加自選
191.890USD
-1.020-0.53%
收盤 07-23 16:00美東報價延遲15分鐘
27.83B總市值
18.43本益比TTM

關於 Resmed Inc 公司

ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.

Resmed Inc簡介

公司代碼RMD
公司名稱Resmed Inc
上市日期Jun 01, 1995
CEOFarrell (Michael J)
員工數量10600
證券類型Ordinary Share
年結日Jun 01
公司地址9001 Spectrum Center Blvd
城市SAN DIEGO
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編92123
電話18587462400
網址https://www.resmed.com/
公司代碼RMD
上市日期Jun 01, 1995
CEOFarrell (Michael J)

Resmed Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Michael J. (Mick) Farrell
Mr. Michael J. (Mick) Farrell
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
449.52K
--
Mr. Ronald R. (Ron) Taylor
Mr. Ronald R. (Ron) Taylor
Lead Independent Director
Lead Independent Director
24.77K
+4.33%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
18.82K
+5.70%
Ms. Harjit Gill
Ms. Harjit Gill
Independent Director
Independent Director
10.94K
+9.46%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
10.60K
+10.12%
Dr. Desney Tan
Dr. Desney Tan
Independent Director
Independent Director
6.00K
+17.88%
Dr. Peter C. Farrell, Ph.D.
Dr. Peter C. Farrell, Ph.D.
Founder and Chairman Emeritus
Founder and Chairman Emeritus
--
--
Mr. Brett A. Sandercock
Mr. Brett A. Sandercock
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jan De Witte
Mr. Jan De Witte
Independent Director
Independent Director
--
--
Mr. Justin M. W. Leong
Mr. Justin M. W. Leong
Chief Product Officer
Chief Product Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael J. (Mick) Farrell
Mr. Michael J. (Mick) Farrell
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
449.52K
--
Mr. Ronald R. (Ron) Taylor
Mr. Ronald R. (Ron) Taylor
Lead Independent Director
Lead Independent Director
24.77K
+4.33%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
18.82K
+5.70%
Ms. Harjit Gill
Ms. Harjit Gill
Independent Director
Independent Director
10.94K
+9.46%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
10.60K
+10.12%
Dr. Desney Tan
Dr. Desney Tan
Independent Director
Independent Director
6.00K
+17.88%

常見問題

Resmed Inc的前五大股東是誰?

Resmed Inc的前五大股東如下:Mr. Michael J. (Mick) Farrell

有多少機構持有Resmed Inc(RMD)的股份?

截至2026Q1,共有1873家機構持有Resmed Inc的股份,合計持有的股份價值約為100.10M,占公司總股份的69.00% 。與2025Q4相比,機構持股有所增加,增幅為-1407565.00。

哪個業務部門對Resmed Inc的收入貢獻最大?

在2026Q1,Devices業務部門對Resmed Inc的收入貢獻最大,創收726.21M,占總收入的51.04% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有